| Literature DB >> 25044933 |
Tanit Arnedo1, Tania López-Hernández, Elena Jeworutzki, Xavier Capdevila-Nortes, Sònia Sirisi, Michael Pusch, Raúl Estévez.
Abstract
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare type of leukodystrophy characterized by white matter edema. Autosomal-recessive mutations in MLC1 cause MLC type 1, and autosomal-recessive or dominant mutations in HEPACAM (also called GLIALCAM) cause MLC type 2A and type 2B, respectively. The role of MLC1 and HEPACAM is unknown, although they have been related with the processes of cell-volume regulation and potassium siphoning by astrocytes. Previous studies with some of the mutations identified in HEPACAM showed that most of them are associated with a trafficking defect. Here, we analyzed biochemically and functionally most mutations identified up-to-date in HEPACAM. Our results allow classifying the effect of mutations in different subtypes and we indicate different cellular mechanisms that lead to MLC pathogenesis.Entities:
Keywords: GLIALCAM; HEPACAM; astrocyte; chloride channels; leukodystrophy
Mesh:
Substances:
Year: 2014 PMID: 25044933 DOI: 10.1002/humu.22622
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878